CELGENE CORP /DE/ 4
4 · ACCELERON PHARMA INC · Filed Jul 6, 2020
Insider Transaction Report
Form 4
CELGENE CORP /DE/
10% Owner
Transactions
- Purchase
Common Stock
2020-07-01$92.50/sh+108,108$9,999,990→ 6,971,772 total
Footnotes (2)
- [F1]This statement is being filed jointly by Celgene Corporation and Bristol-Myers Squibb Company.
- [F2]These shares are owned directly by Celgene Corporation, which is a wholly owned subsidiary of Bristol-Myers Squibb Company. Bristol-Myers Squibb Company is an indirect beneficial owner of the reported securities.